Syndexa Pharmaceuticals Corp., a Cambridge, Mass.-based metabolic drug discovery company, has raised $15 million in venture capital funding. The round was led by Yalcin Ayalsi, founder of Hitite Microwave Corp. www.syndexa.com
Syndexa Pharmaceuticals Corp., a Cambridge, Mass.-based metabolic drug discovery company, has raised $15 million in venture capital funding. The round was led by Yalcin Ayalsi, founder of Hitite Microwave Corp. www.syndexa.com
Copyright PEI Media
Not for publication, email or dissemination